30 Day

Assessing Sleepwhale CBN for Enhanced Sleep Quality

STUDY TITLE Assessing Sleepwhale CBN for Enhanced Sleep Quality
Submitted under umbrella

Minimal Risk Citizen Science Umbrella Protocol

Date submitted

-

End date

There is no pre-specified end date and sub-studies remain open long-term.

Language

English

Efforia AI IRB approval recommendation

Recruitment page preview

Preview

Author edit

Edit

Informed consent

Review

Study author

ak wa

Principal investigator

Matthew Amsden

Sub-Investigator for Adverse Events

Dr. Viral Patel

Description

This protocol focuses on introducing Sleepwhale CBN (cannabinol) to participants to evaluate its effects on improving deep sleep and REM sleep. Participants are encouraged to follow a structured routine that incorporates Sleepwhale CBN at specific times to promote restful sleep.

Participant engagement length

30 Days

Sponsor

This study is made possible by your payment to cover all supplies and expenses required to participate.

Cost to participant

$0

Included products & services
Sleepwhale CBN (cannabinol): $38
Outcome measures
Methodology

Single Arm longitudinal where participants act as their own control

Basic or advanced dissemination plan

Basic

Deviation from recruitment approach

No

Deviation from statistical approach

No

Will study include “more about you questions”

No

Clinicaltrials.Gov

Yes

Committment to list findings on clinicaltrials.Gov

Yes

This document is prepared with the assistance of AI, but is reviewed by a human.

Rational & Study Design

The Intervention

Included Products & Services

Product Name: Sleepwhale CBN (cannabinol)

Quantity included: 30

Price: $38.00

Product Description: CBN is intended for nighttime use. Take 15 minutes before bedtime for deeper, more restful sleep. This product can be taken with Sleep Drops Regular or Extra Strength if you are looking for more sedation.

Product Image:

Ingredients:

Product Safety:

Study Design & Methodology

Inappropriate Participants & Inclusion/Exclusion

Study Design & Experience

Statistical Analysis Plan

Limitations & Justification

Human Subjects Ethics

Suitability Under Minimal Risk Umbrella Protocol

Suitability for Pay to Participate Model

Human Subjects Protection Questionnaire